Pilot Study on the Efficacy of Pascoflair in an Acute Stressful Situation (TSST)

Inclusion Criteria:

* Provide written informed consent;
* Healthy male and female subjects
* Non-smoker;
* Age 25 to 45 years;
* BMI ≥ 19 to ≤ 30 kg/m2

Exclusion Criteria:

* Any known allergies to the test substance;
* Any known addiction to drugs, alcohol or positive results in the drug screening test;
* Any serious general illness, ongoing or within the last 12 months;
* Any febrile illness (\> 24 hrs.) within 7 days prior to treatment;
* Any antibiotics for the last four weeks before study inclusion;
* Diabetes mellitus;
* Known heart disease, hypertension, kidney disease, significant respiratory disease, epilepsy, or rheumatoid arthritis;
* Known immunologic or infectious disease (e.g. hepatitis, tuberculosis, HIV or AIDS) which could place the subject at risk or interfere with the accuracy of the study results;
* Pregnancy or lactating;
* Current participation or participation in any type of clinical study in the past week;
* Current or past participation in a TSST study;
* Employees of the Sponsor or the CRO;
* Any other medication that, in the opinion of the Investigator is likely to affect their response to treatment;
* Clinically relevant abnormalities in physical examinations, vital signs, clinical chemistry, or haematology as judged by the Investigator;
* Any other condition the Investigator or their duly assigned representatives believes may affect the ability of the individual to complete the study or the interpretation of the study results.